Medicines Co (MDCO) Q1 2019 Earnings Call Transcript
MDCO earnings call for the period ending March 31, 2019.
The Medicines Company
MDCO
MDCO
$32.90
-$0.35
-1.1%
BATS BZX Real Time Price as of May 23, 2019, 10:52 a.m.
View Interactive MDCO Charts
A pharmaceutical company provides innovative, cost effective acute care hospital products to the worldwide hospital marketplace.
News & Analysis: The Medicines Company
The Fool has written over 100 articles on The Medicines Company.
All
Market Moves
Earnings
Medicines Co (MDCO) Q4 2018 Earnings Conference Call Transcript
MDCO earnings call for the period ending December 31, 2018.
Here's Why Shares of The Medicines Company Sank 14.5% Today
Investors aren't happy about the drugmaker's latest capital raise.
3 Top Cholesterol Drug Stocks to Consider Buying Now
These three biotech stocks are on a path to growth that relies on treating cholesterol with novel new drugs.
3 Biotech Stocks That Soared This Week: Are They Buys?
These biotech stocks jumped by 35% or more over the last few days. But can their momentum continue?
Why The Medicinces Company Is Having an Outstanding Week
An analyst day is giving shares a boost.
This Is Why Alnylam Pharmaceuticals Soared 249% in 2017
It was a breakout year for the clinical-stage biotech.
5 Deadliest Diseases in the U.S. -- and the Top Drugs Potentially on the Way to Treat Them
Promising treatments could be on the way to address the diseases causing the most American deaths.
How This Company Is Taking on Amgen
The Medicines Company is developing a new drug that could give Amgen's Repatha a run for its money in lowering bad cholesterol levels.
Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today
Shares of several biotech companies dropped after Amgen released important data from a long-term clinical trial that came up short of Wall Street's expectations.
